GLENMARK Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > glenmark

Technical Analysis

Technical Strength: 8.1 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 60.3. According to RSI analysis, glenmark is technically strong. 9.0 GLENMARK RSI Chart
MACD (?) MACD: 9.21 and Signal Line: 6.59. According to MACD analysis, glenmark is technically strong. 8.0 GLENMARK MACD Chart
Simple Moving Average (?) According to simple moving average analysis, glenmark is in a strong uptrend. Major support levels are 430.275, 425.542, 340.5127. 10.0 GLENMARK Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, glenmark is in a strong uptrend. Major support levels are 436.7846, 415.7474, 378.6769. 10.0 GLENMARK Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.868. According to bollinger bands, glenmark is technically strong. 7.0 GLENMARK Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above 61.8% level. Support is at 429.9521 Resistance levels are 457.275 and 484.5979. 6.5 GLENMARK Fibonacci Retracement Chart
Average True Range (?) ATR: 16.8 NA GLENMARK Average True Range Chart
Average Directional Index (?) ADX is 21.5 which means GLENMARK is in a trading range and there is no trend. NA GLENMARK Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
August 07, 2020
Open Price 463.45
High Price 466.9
Low Price 451.0
Close Price 453.45
Absolute Change -7.75
Percentage Change -1.68%
Weekly Change 0.243%
Monthly Change 6.28%
Yearly Change 8.51%
52-week high 573.05
52-week low 161.65
Corporate Actions
ExDate Purpose
September 19, 2019 AGM/DIV-RS 2 PER SH
September 19, 2018 AGM/DIV-RS 2 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.611
Confidence in Beta1.29%
Market Capital Rs. 12301.0 Cr
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 07 August 2020: Deliverable Quantity:8.24e+05 NA GLENMARK Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 07 August 2020: Daily Volatility:0.6687 NA GLENMARK Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 07 August 2020: PCR_OI:0.507 PCR:0.204 NA GLENMARK PCR Chart
Option Pain (?) 07 August 2020: Max Pain:450.0 NA GLENMARK Option Pain Chart
Premium (?) 07 August 2020 Premium: 2.05 Futures OI:6497500.0 NA GLENMARK Premium Chart
Option_MAX_OI (?) 07 August 2020: Price:453.45 Put with maximum OI:400.0 Call with maximum OI:500.0 NA GLENMARK Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
August 27, 2020 455.5 6497500.0 3119.0 3119.0 453.45
September 24, 2020 455.4 131100.0 28.0 28.0 453.45
October 29, 2020 446.5 0.0 0.0 0.0 453.45


October 01, 2018 Shareholders meeting Proceedings and Scrutinizer''s Report of the 40th Annual General Meeting {AGM) of Glenmark Pharmaceuticals Limited (''the Company'') held on September 28, 2018
August 13, 2018 News Clarification The Exchange has sought clarification from the Company with respect to news item captioned- True North in talks to buy into Glenmark API biz for Rs 1500 crIn this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.
See all Announcements

Board Meetings

Date Meeting Date Purpose
August 06, 2020 August 14, 2020 Financial Results To consider and approve the financial results for the period ended Jun 30, 2020
June 18, 2020 June 26, 2020 Financial Results/Dividend To consider and approve the financial results for the period ended March 31, 2020 and dividend
See all Board Meetings

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play